Targeting endothelial cell metabolism in cancerous microenvironment: a new approach for anti-angiogenic therapy

References

• Aird WC. 2012. Endothelial cell heterogeneity. Cold Spring Harb Perspect Med. 2(1):a006429.
   PubMed Web of Science ®Google Scholar
• Akella NM, Ciraku L, Reginato MJ. 2019. Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer. BMC Biol. 17(1):52.
   PubMed Web of Science ®Google Scholar
• Ammazzalorso A, De Filippis B, Giampietro L, Amoroso R. 2017. N-acylsulfonamides: Synthetic routes and biological potential in medicinal chemistry. Chem Biol Drug Des. 90(6):1094–1105.
   PubMed Web of Science ®Google Scholar
• Annan DA, Maishi N, Soga T, Dawood R, Li C, Kikuchi H, Hojo T, Morimoto M, Kitamura T, Alam MT, et al. 2019. Carbonic anhydrase 2 (CAII) supports tumor blood endothelial cell survival under lactic acidosis in the tumor microenvironment. Cell Commun Signal. 17(1):169.
   PubMed Web of Science ®Google Scholar
• Baghban R, Roshangar L, Jahanban-Esfahlan R, Seidi K, Ebrahimi-Kalan A, Jaymand M, Kolahian S, Javaheri T, Zare P. 2020. Tumor microenvironment complexity and therapeutic implications at a glance. Cell Commun Signal. 18(1):59.
   PubMed Web of Science ®Google Scholar
• Boyd S, Brookfield JL, Critchlow SE, Cumming IA, Curtis NJ, Debreczeni J, Degorce SL, Donald C, Evans NJ, Groombridge S, et al. 2015. Structure-based design of potent and selective inhibitors of the metabolic kinase PFKFB3. J Med Chem. 58(8):3611–3625.
   PubMed Web of Science ®Google Scholar
• Brisson L, Bański P, Sboarina M, Dethier C, Danhier P, Fontenille M-J, Van Hée VF, Vazeille T, Tardy M, Falces J, et al. 2016. Lactate dehydrogenase B controls lysosome activity and autophagy in cancer. Cancer Cell. 30(3):418–431.
   PubMed Web of Science ®Google Scholar
• Bruning U, Morales-Rodriguez F, Kalucka J, Goveia J, Taverna F, Queiroz KCS, Dubois C, Cantelmo AR, Chen R, Loroch S, et al. 2018. Impairment of angiogenesis by fatty acid synthase inhibition involves mTOR malonylation. Cell Metab. 28(6):866–880.
   PubMed Web of Science ®Google Scholar
• Cantelmo AR, Conradi LC, Brajic A, Goveia J, Kalucka J, Pircher A, Chaturvedi P, Hol J, Thienpont B, Teuwen LA, et al. 2016. Inhibition of the glycolytic activator PFKFB3 in endothelium induces tumor vessel normalization, impairs metastasis, and improves chemotherapy. Cancer Cell. 30(6):968–985.
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Njah K, Hong W. 2020. Agrin mediates angiogenesis in the tumor microenvironment. Trends Cancer. 6(2):81–85. eng.
   PubMed Web of Science ®Google Scholar
• Ciesielski O, Biesiekierska M, Panthu B, Vialichka V, Pirola L, Balcerczyk A. 2020. The epigenetic profile of tumor endothelial cells. effects of combined therapy with antiangiogenic and epigenetic drugs on cancer progression. IJMS. 21(7):2606.
   Web of Science ®Google Scholar
• Daghigh F, Fukuto JM, Ash DE. 1994. Inhibition of rat liver arginase by an intermediate in NO biosynthesis, NG-Hydroxy-L-arginine: implications for the regulation of nitric oxide biosynthesis by arginase. Biochem Biophys Res Commun. 202(1):174–180.
   PubMed Web of Science ®Google Scholar
• De Bock K, Georgiadou M, Schoors S, Kuchnio A, Wong BW, Cantelmo AR, Quaegebeur A, Ghesquiere B, Cauwenberghs S, Eelen G, et al. 2013. Role of PFKFB3-driven glycolysis in vessel sprouting. Cell. 154(3):651–663.
   PubMed Web of Science ®Google Scholar
• Draoui N, de Zeeuw P, Carmeliet P. 2017. Angiogenesis revisited from a metabolic perspective: role and therapeutic implications of endothelial cell metabolism. Open Biol. 7(12):170219.
   PubMed Web of Science ®Google Scholar
• Eelen G, de Zeeuw P, Simons M, Carmeliet P. 2015. Endothelial cell metabolism in normal and diseased vasculature. Circ Res. 116(7):1231–1244.
   PubMed Web of Science ®Google Scholar
• Eelen G, de Zeeuw P, Treps L, Harjes U, Wong BW, Carmeliet P. 2018. Endothelial cell metabolism. Physiol Rev. 98(1):3–58. eng.
   PubMed Web of Science ®Google Scholar
• Elice F, Rodeghiero F. 2012. Side effects of anti-angiogenic drugs. Thrombosis Research. 129:S50–S53.
   PubMed Web of Science ®Google Scholar
• Falkenberg KD, Rohlenova K, Luo Y, Carmeliet P. 2019. The metabolic engine of endothelial cells. Nat Metab. 1(10):937–946.
   PubMedGoogle Scholar
• Fitzgerald G, Soro-Arnaiz I, De Bock K. 2018. The Warburg effect in endothelial cells and its potential as an anti-angiogenic target in cancer. Front Cell Dev Biol. 6:100.
   PubMed Web of Science ®Google Scholar
• Ghanbari Movahed Z, Rastegari-Pouyani M, Mohammadi M, Mansouri K. 2019. Cancer cells change their glucose metabolism to overcome increased ROS: one step from cancer cell to cancer stem cell? Biomed Pharmacother. 112:108690.
   PubMed Web of Science ®Google Scholar
• Ghinea N. 2021. Anti-angiogenic therapy: albumin-binding proteins could mediate mechanisms underlying the accumulation of small molecule receptor tyrosine kinase inhibitors in normal tissues with potential harmful effects on health. Diseases. 9(2):28.
   PubMed Web of Science ®Google Scholar
• Goveia J, Stapor P, Carmeliet P. 2014. Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease. EMBO Mol Med. 6(9):1105–1120.
   PubMed Web of Science ®Google Scholar
• Gross MI, Demo SD, Dennison JB, Chen L, Chernov-Rogan T, Goyal B, Janes JR, Laidig GJ, Lewis ER, Li JJ, et al. 2014. Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer. Mol Cancer Ther. 13(4):890–901.
   PubMed Web of Science ®Google Scholar
• Harjes U, Bensaad K, Harris AL. 2012. Endothelial cell metabolism and implications for cancer therapy. Br J Cancer. 107(8):1207–1212.
   PubMed Web of Science ®Google Scholar
• Heske CM. 2019. Beyond energy metabolism: exploiting the additional roles of NAMPT for cancer therapy. Front Oncol. 9:1514.
   PubMed Web of Science ®Google Scholar
• Hida K, Hida Y, Shindoh M. 2008. Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies. Cancer Sci. 99(3):459–466.
   PubMed Web of Science ®Google Scholar
• Iacovelli R, Palazzo A, Procopio G, Santoni M, Trenta P, De Benedetto A, Mezi S, Cortesi E. 2014. Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy. Br J Clin Pharmacol. 77(6):929–938.
   PubMed Web of Science ®Google Scholar
• Ikeuchi H, Ahn Y-M, Otokawa T, Watanabe B, Hegazy L, Hiratake J, Richards N. 2012. A sulfoximine-based inhibitor of human asparagine synthetase kills L-asparaginase-resistant leukemia cells. Bioorg Med Chem. 20(19):5915–5927.
   PubMed Web of Science ®Google Scholar
• Jahani M, Noroznezhad F, Mansouri K. 2018. Arginine: challenges and opportunities of this two-faced molecule in cancer therapy. Biomed Pharmacother. 102:594–601.
   PubMed Web of Science ®Google Scholar
• Jahani M, Rezazadeh D, Mohammadi P, Abdolmaleki A, Norooznezhad A, Mansouri K. 2020. Regenerative medicine and angiogenesis; challenges and opportunities. Adv Pharm Bull. 10(4):490–501.
   PubMed Web of Science ®Google Scholar
• Jones W, Bianchi K. 2015. Aerobic glycolysis: beyond proliferation. Front Immunol. 6:227–227.
   PubMed Web of Science ®Google Scholar
• Kalucka J, Bierhansl L, Conchinha NV, Missiaen R, Elia I, Bruning U, Scheinok S, Treps L, Cantelmo AR, Dubois C, et al. 2018. Quiescent endothelial cells upregulate fatty acid beta-oxidation for vasculoprotection via redox homeostasis. Cell Metab. 28(6):881–894.
   PubMed Web of Science ®Google Scholar
• Kardideh B, Samimi Z, Norooznezhad F, Kiani S, Mansouri K. 2019. Autophagy, cancer and angiogenesis: where is the link? Cell Biosci. 9(1):65.
   PubMed Web of Science ®Google Scholar
• Kim B, Jang C, Dharaneeswaran H, Li J, Bhide M, Yang S, Li K, Arany Z. 2018. Endothelial pyruvate kinase M2 maintains vascular integrity. J Clin Investigation. 128:4543–4556.
   PubMed Web of Science ®Google Scholar
• Koroniak L, Ciustea M, Gutierrez JA, Richards NGJ. 2003. Synthesis and characterization of an N-Acylsulfonamide inhibitor of human asparagine synthetase. Org Lett. 5(12):2033–2036.
   PubMed Web of Science ®Google Scholar
• Li X, Kumar A, Carmeliet P. 2019. Metabolic pathways fueling the endothelial cell drive. Annu Rev Physiol. 81:483–503.
   PubMed Web of Science ®Google Scholar
• Li X, Sun X, Carmeliet P. 2019. Hallmarks of endothelial cell metabolism in health and disease. Cell Metab. 30(3):414–433.
   PubMed Web of Science ®Google Scholar
• Lin T-C. 2022. Updated functional roles of NAMPT in carcinogenesis and therapeutic niches. Cancers. 14(9):2059.
   PubMed Web of Science ®Google Scholar
• Lugano R, Ramachandran M, Dimberg A. 2020. Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell Mol Life Sci. 77(9):1745–1770.
   PubMed Web of Science ®Google Scholar
• Lupo G, Caporarello N, Olivieri M, Cristaldi M, Motta C, Bramanti V, Avola R, Salmeri M, Nicoletti F, Anfuso CD. 2016. Anti-angiogenic therapy in cancer: downsides and new pivots for precision medicine. Front Pharmacol. 7:519.
   PubMed Web of Science ®Google Scholar
• Maishi N, Annan DA, Kikuchi H, Hida Y, Hida K. 2019. Tumor endothelial heterogeneity in cancer progression. Cancers. 11(10):1511.
   PubMed Web of Science ®Google Scholar
• Marcu R, Choi YJ, Xue J, Fortin CL, Wang Y, Nagao RJ, Xu J, MacDonald JW, Bammler TK, Murry CE, et al. 2018. Human organ-specific endothelial cell heterogeneity. iScience. 4:20–35.
   PubMed Web of Science ®Google Scholar
• Marcu R, Zheng Y, Hawkins BJ. 2017. Mitochondria and angiogenesis. Adv Exp Med Biol. 982:371–406.
   PubMed Web of Science ®Google Scholar
• Margadant C. 2020. Positive and negative feedback mechanisms controlling tip/stalk cell identity during sprouting angiogenesis. Angiogenesis. 23(2):75–77.
   PubMed Web of Science ®Google Scholar
• Mishra D, Banerjee D. 2019. Lactate dehydrogenases as metabolic links between tumor and stroma in the tumor microenvironment. Cancers. 11(6):750.
   PubMed Web of Science ®Google Scholar
• Novellasdemunt L, Bultot L, Manzano A, Ventura F, Rosa JL, Vertommen D, Rider MH, Navarro-Sabate A, Bartrons R. 2013. PFKFB3 activation in cancer cells by the p38/MK2 pathway in response to stress stimuli. Biochem J. 452(3):531–543.
   PubMed Web of Science ®Google Scholar
• Ohga N, Ishikawa S, Maishi N, Akiyama K, Hida Y, Kawamoto T, Sadamoto Y, Osawa T, Yamamoto K, Kondoh M, et al. 2012. Heterogeneity of tumor endothelial cells: comparison between tumor endothelial cells isolated from high- and low-metastatic tumors. Am J Pathol. 180(3):1294–1307.
   PubMed Web of Science ®Google Scholar
• Ohmura-Kakutani H, Akiyama K, Maishi N, Ohga N, Hida Y, Kawamoto T, Iida J, Shindoh M, Tsuchiya K, Shinohara N, et al. 2014. Identification of tumor endothelial cells with high aldehyde dehydrogenase activity and a highly angiogenic phenotype. PLoS One. 9(12):e113910.
   PubMed Web of Science ®Google Scholar
• Pasquier J, Ghiabi P, Chouchane L, Razzouk K, Rafii S, Rafii A. 2020. Angiocrine endothelium: from physiology to cancer. J Transl Med. 18(1):52.
   PubMed Web of Science ®Google Scholar
• Pedersen AK, Mendes Lopes de Melo J, Mørup N, Tritsaris K, Pedersen SF. 2017. Tumor microenvironment conditions alter Akt and Na+/H + exchanger NHE1 expression in endothelial cells more than hypoxia alone: implications for endothelial cell function in cancer. BMC Cancer. 17(1):542.
   PubMed Web of Science ®Google Scholar
• Peyton KJ, Liu XM, Yu Y, Yates B, Behnammanesh G, Durante W. 2018. Glutaminase-1 stimulates the proliferation, migration, and survival of human endothelial cells. Biochem Pharmacol. 156:204–214.
   PubMed Web of Science ®Google Scholar
• Pontes-Quero S, Fernández-Chacón M, Luo W, Lunella FF, Casquero-Garcia V, Garcia-Gonzalez I, Hermoso A, Rocha SF, Bansal M, Benedito R. 2019. High mitogenic stimulation arrests angiogenesis. Nat Commun. 10(1):2016.
   PubMed Web of Science ®Google Scholar
• Qin Z, Xiang C, Zhong F, Liu Y, Dong Q, Li K, Shi W, Ding C, Qin L, He F. 2019. Transketolase (TKT) activity and nuclear localization promote hepatocellular carcinoma in a metabolic and a non-metabolic manner. J Exp Clin Cancer Res. 38(1):154.
   PubMed Web of Science ®Google Scholar
• Rahimi N. 2019. Glycosylation in the tumor microenvironment: implications for tumor angiogenesis and metastasis.
   Google Scholar
• Rajappa M, Saxena P, Kaur J. 2010. Chapter 6 – ocular angiogenesis: mechanisms and recent advances in therapy. In Makowski GS, editor. Advances in Clinical Chemistry. Amsterdam: Elsevier; p. 103–121.
   Google Scholar
• Rao N, Lee YF, Ge R. 2015. Novel endogenous angiogenesis inhibitors and their therapeutic potential. Acta Pharmacol Sin. 36(10):1177–1190.
   PubMed Web of Science ®Google Scholar
• Rohlenova K, Veys K, Miranda-Santos I, De Bock K, Carmeliet P. 2018. Endothelial cell metabolism in health and disease. Trends Cell Biol. 28(3):224–236.
   PubMed Web of Science ®Google Scholar
• Schoonjans CA, Mathieu B, Joudiou N, Zampieri LX, Brusa D, Sonveaux P, Feron O, Gallez B. 2020. Targeting endothelial cell metabolism by inhibition of pyruvate dehydrogenase kinase and glutaminase-1. JCM. 9(10):3308.
   Web of Science ®Google Scholar
• Schoors S, De Bock K, Cantelmo AR, Georgiadou M, Ghesquiere B, Cauwenberghs S, Kuchnio A, Wong BW, Quaegebeur A, Goveia J, et al. 2014. Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis. Cell Metab. 19(1):37–48.
   PubMed Web of Science ®Google Scholar
• Udupa S, Nguyen S, Hoang G, Nguyen T, Quinones A, Pham K, Asaka R, Nguyen K, Zhang C, Elgogary A, et al. 2019. Upregulation of the glutaminase II pathway contributes to glutamate production upon glutaminase 1 inhibition in pancreatic cancer. Proteomics. 19(21–22):e1800451.
   PubMed Web of Science ®Google Scholar
• van Beijnum JR, Dings RP, van der Linden E, Zwaans BM, Ramaekers FC, Mayo KH, Griffioen AW. 2006. Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature. Blood. 108(7):2339–2348.
   PubMed Web of Science ®Google Scholar
• Vandekeere S, Dewerchin M, Carmeliet P. 2015. Angiogenesis revisited: an overlooked role of endothelial cell metabolism in vessel sprouting. Microcirculation. 22(7):509–517.
   PubMed Web of Science ®Google Scholar
• Vandekeere S, Dubois C, Kalucka J, Sullivan MR, Garcia-Caballero M, Goveia J, Chen R, Diehl FF, Bar-Lev L, Souffreau J, et al. 2018. Serine synthesis via PHGDH is essential for heme production in endothelial cells. Cell Metab. 28(4):573–587.e513.
   PubMed Web of Science ®Google Scholar
• Verdegem D, Moens S, Stapor P, Carmeliet P. 2014. Endothelial cell metabolism: parallels and divergences with cancer cell metabolism. Cancer Metab. 2:19.
   PubMedGoogle Scholar
• Wei X, Schneider JG, Shenouda SM, Lee A, Towler DA, Chakravarthy MV, Vita JA, Semenkovich CF. 2011. De novo lipogenesis maintains vascular homeostasis through endothelial nitric-oxide synthase (eNOS) palmitoylation. J Biol Chem. 286(4):2933–2945.
   PubMed Web of Science ®Google Scholar
• Yalcin A, Clem BF, Imbert-Fernandez Y, Ozcan SC, Peker S, O'Neal J, Klarer AC, Clem AL, Telang S, Chesney J. 2014. 6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27. Cell Death Dis. 5:e1337.
   PubMed Web of Science ®Google Scholar
• Yalcin A, Clem BF, Simmons A, Lane A, Nelson K, Clem AL, Brock E, Siow D, Wattenberg B, Telang S, et al. 2009. Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases. J Biol Chem. 284(36):24223–24232.
   PubMed Web of Science ®Google Scholar
• Yang Z, Ming X-F. 2013. Arginase: the emerging therapeutic target for vascular oxidative stress and inflammation. Front Immunol. 4:149–149.
   PubMed Web of Science ®Google Scholar
• Yetkin-Arik B, Vogels IMC, Nowak-Sliwinska P, Weiss A, Houtkooper RH, Van Noorden CJF, Klaassen I, Schlingemann RO. 2019. The role of glycolysis and mitochondrial respiration in the formation and functioning of endothelial tip cells during angiogenesis. Sci Rep. 9(1):12608.
   PubMed Web of Science ®Google Scholar
• Yoshida GJ. 2015. Metabolic reprogramming: the emerging concept and associated therapeutic strategies. J Exp Clin Cancer Res. 34:111.
   PubMed Web of Science ®Google Scholar
• Yu X, Li S. 2017. Non-metabolic functions of glycolytic enzymes in tumorigenesis. Oncogene. 36(19):2629–2636.
   PubMed Web of Science ®Google Scholar
• Zecchin A, Kalucka J, Dubois C, Carmeliet P. 2017. How endothelial cells adapt their metabolism to form vessels in tumors. Front Immunol. 8:1750.
   PubMed Web of Science ®Google Scholar
• Zhu L, Gu Q, Fang L. 2019. Cholesterol-mediated regulation of angiogenesis: an emerging paradigm. Cardiology Plus. 4(1):1–9.
   Google Scholar
• Zhu W, Radadiya A, Bisson C, Wenzel S, Nordin BE, Martínez-Márquez F, Imasaki T, Sedelnikova SE, Coricello A, Baumann P, et al. 2019. High-resolution crystal structure of human asparagine synthetase enables analysis of inhibitor binding and selectivity. Commun Biol. 2(1):345.
   PubMed Web of Science ®Google Scholar